05:07 PM EDT, 03/19/2025 (MT Newswires) -- Jasper Therapeutics ( JSPR ) filed a registration statement Wednesday for the potential sale of up to $300 million of securities from time to time in one or more offerings.
The filing covers common and preferred stock, debt securities, warrants, rights, units, and depositary shares.
The company plans to use the net proceeds for general corporate purposes.